Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/05/24
Country: United States
Summary: Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb is capable of inhibiting two proangiogenics fators and a combined blockade of them has a greater inhibitory efficacy compared with inhibition of either factor alone. It is designed for the research of Colorectal cancer (CRC); Solid tumors; Wet AMD (Age-related macular degeneration); Diabetic macular edema therapy.https://www.creative-biolabs.com/bsab/symbolsearch-ang2%2520%2526%2520vegfa.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
